BRIEF published on 01/10/2025 at 13:05, 1 year 3 months ago Lumira Ventures Promotes Suman Rao to Principal Healthcare Innovation Venture Capital Lumira Ventures Suman Rao Principal Promotion
BRIEF published on 01/10/2025 at 13:05, 1 year 3 months ago Lumira Ventures promeut Suman Rao au poste de directeur Capital-risque Lumira Ventures Innovation Dans Le Domaine De La Santé Suman Rao Promotion Principale
PRESS RELEASE published on 01/10/2025 at 13:00, 1 year 3 months ago Lumira Ventures Announces Promotion of Suman Rao to Principal Lumira Ventures promotes Suman Rao, Ph.D., to Principal, recognizing her contributions to healthcare innovation. Read more about her journey and achievements Healthcare Innovation Venture Capital Lumira Ventures Biomedical Suman Rao
BRIEF published on 06/26/2024 at 13:05, 1 year 9 months ago Lumira Ventures Promotes Nikhil Thatte to Partner Promotion Life Sciences Lumira Ventures Healthcare Investment Nikhil Thatte
BRIEF published on 06/26/2024 at 13:05, 1 year 9 months ago Lumira Ventures promeut Nikhil Thatte comme partenaire Promotion Lumira Ventures Investissement Dans La Santé Sciences De La Vie Nikhil Thatte
PRESS RELEASE published on 06/26/2024 at 13:00, 1 year 9 months ago Lumira Ventures Announces Promotion of Nikhil Thatte to Partner Lumira Ventures promotes Nikhil Thatte to Partner in recognition of his exceptional contributions to healthcare innovation. Nikhil's strategic insights drive firm's success and partnerships Life Sciences Healthcare Innovation Lumira Ventures Investment Firm Nikhil Thatte
BRIEF published on 04/02/2024 at 13:05, 2 years ago Lumira Ventures Invests in Nocion Therapeutics to Advance Chronic Cough Treatment Lumira Ventures Nocion Therapeutics Chronic Cough Treatment Phase 2b Study Series B Financing
BRIEF published on 04/02/2024 at 13:05, 2 years ago Lumira Ventures investit dans Nocion Therapeutics pour faire progresser le traitement de la toux chronique Lumira Ventures Financement De Série B Nocion Thérapeutique Traitement De La Toux Chronique Étude De Phase 2b
PRESS RELEASE published on 04/02/2024 at 13:00, 2 years ago Lumira Ventures Announces Investment in Nocion Therapeutics to Revolutionize Chronic Cough Treatment Lumira Ventures invests in Nocion Therapeutics' Taplucanium for Chronic Cough treatment. Series B funding of $70M secured from leading investors Series B Funding Lumira Ventures Nocion Therapeutics Taplucanium Chronic Cough
BRIEF published on 03/07/2024 at 13:05, 2 years 1 month ago Lumira Ventures Celebrates Team Promotions Ahead of International Women's Day Healthcare Innovation Gender Equality International Women's Day Lumira Ventures Team Promotions
Published on 04/14/2026 at 17:00, 13 minutes ago Intention to List on the Namibia Securities Exchange
Published on 04/14/2026 at 15:05, 2 hours 8 minutes ago Karbon-X Expands Canadian Compliance Offering as Regulatory Deadlines Approach Across Federal and Provincial Carbon Markets
Published on 04/14/2026 at 15:00, 2 hours 13 minutes ago Datavault AI and AgSensor Solutions Announce Consulting Partnership to Tokenize High-Value Agricultural Data Assets
Published on 04/14/2026 at 14:55, 2 hours 18 minutes ago BEACN Introduces Voice-First Headset as It Expands Its Creator Audio Platform
Published on 04/14/2026 at 14:30, 2 hours 43 minutes ago Goldcliff Extends Kettle Valley Drill Permit to 2028 and Completes Trench Program Advancing North Cliff Zone Targets
Published on 04/14/2026 at 17:03, 9 minutes ago Kickoff for automated drone defense from Brandenburg: Joint venture ONBERG begins operations
Published on 04/14/2026 at 17:00, 12 minutes ago Vesper Next Generation Infrastructure Fund I, and co-investment initiatives, reach final close surpassing in aggregate EUR 1bn of total AuM, the most successful debut mid-market infrastructure funds since 2023
Published on 04/14/2026 at 16:00, 1 hour 12 minutes ago Open-air driving pleasure in the new Porsche 911 GT3 S/C
Published on 04/14/2026 at 15:18, 1 hour 54 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 04/14/2026 at 15:17, 1 hour 55 minutes ago Form 8.3 - The Vanguard Group, Inc.: Senior plc
Published on 04/14/2026 at 17:00, 13 minutes ago FinanceWire Introduces Certidox to Enable Verifiable Press Releases as Fake Content Becomes Indistinguishable from Reality
Published on 04/14/2026 at 17:00, 13 minutes ago FinanceWire intègre Certidox pour permettre la vérification des communiqués de presse, alors que les contenus falsifiés deviennent impossibles à distinguer de la réalité
Published on 04/14/2026 at 08:30, 8 hours 43 minutes ago ALPOU - Groupe POULAILLON - Projet offre publique d'achat obligatoire
Published on 04/13/2026 at 19:14, 21 hours 58 minutes ago ALTAREA - Déclaration d’opérations sur actions propres
Published on 04/13/2026 at 18:15, 22 hours 58 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/03/2026
